Results 1 to 10 of about 12,890,416 (254)

Dermatologic immune-related adverse events associated with immune checkpoint inhibitors: A prospective real-world observational study in Switzerland. [PDF]

JAAD Int
Trösch A, Zahn CA, Cazzaniga S, Özdemir BC, Feldmeyer L, Benzaquen M.   +5 more
europepmc   +1 more source

Immune checkpoint inhibitor-related intestinal pseudo-obstruction and multisystem immune-related adverse events in a post-gastrectomy patient: a case report and literature review. [PDF]

Front Oncol
Liu Z, Wang C, Shen Y, Shi Y, Duan J, Dong H, Xu Y, Zheng Y, Cui H.   +8 more
europepmc   +1 more source

Metachronous severe multisystem immune-related adverse events during tremelimumab plus durvalumab therapy for hepatocellular carcinoma: a clinicopathological autopsy case report. [PDF]

Front Oncol
Nosaka T, Yamashita J, Akazawa Y, Tanaka T, Takahashi K, Naito T, Ohtani M, Kimura Y, Imamura Y, Tada H, Kobayashi M, Nakamoto Y.   +11 more
europepmc   +1 more source

Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort study. [PDF]

Gut
Fang J, Zhong S, Wang T, He K, Mu A, Ong M, Lin Y, Zhu Z, Wang N, Wu J, Wang Z, Li Z, Gao F, Zhuang L, Guo Z, Zheng S, Li H, Zhang S, Ling Q.   +18 more
europepmc   +1 more source

Case Report: Neurological immune-related adverse events with anti-PD-1 based immunotherapy in cervical cancer. [PDF]

Front Oncol
Passarella G, Vella S, Ferrario E, Provinciali N, Cortinovis DL, Canova S.   +5 more
europepmc   +1 more source

Antibiotic use and immune-related adverse events in patients treated with immune checkpoint inhibitors: analysis of the FAERS database. [PDF]

Front Immunol
Yu J, Li Q, Zou S, Rong Y, Zhang Y, Chen C.   +5 more
europepmc   +1 more source

Immune-related adverse events between elderly patients with gastrointestinal and lung cancers: A real-world study. [PDF]

Chin Med J (Engl)
Chan I, Kong L, Jia B, Dong F, He Y, Ji X, Ren G, Wang L, Lu Z, Shen L, Wang Y.   +10 more
europepmc   +1 more source

Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events

Cancers, 2023
Virginia Arrazubi, David Escors-Murugarren, Mireia Martinez Kareaga   +2 more
exaly  

Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study

Cancers, 2021
Yiqing Huang, Nisha Suyien Chandran, Folefac Aminkeng   +2 more
exaly